Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose-finding and safety study for tracheal intubation under dissociative anesthesia
ChiCTR2000035650Phase 4Not yet recruiting
- Sponsor
- Shandong Second People's Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in None (5 arms), sponsored by Shandong Second People's Hospital. Primary endpoints: Changes in hemodynamics at each time point, Changes in blood sugar and 5 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2000035650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035650.